Tags Reports - Allied Market Research

sale

Acne Medication Market

P

2024

Acne Medication Market: Global Opportunity Analysis and Industry Forecast, 2023 - 2035

The global acne medication market was valued at $13.4 billion in 2023, and is projected to reach $24.2 billion by 2035, growing at a CAGR of 5.1% from 2024 to 2035.

Report Code : * A04007 | Pages : 280 | Category : Life Sciences

Price:

~~$3,570~~ $2,499 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Medication Management Market

P

2024

Medication Management Market: Global Opportunity Analysis and Industry Forecast, 2024 - 2033

The global medication management market was valued at $3.0 billion in 2023, and is projected to reach $8.2 billion by 2033, growing at a CAGR of 10.6% from 2024 to 2033.

Report Code : A10470 | Pages : 310 | Category : Life Sciences

Price:

~~$2,655~~ $1,859 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Mexico Myasthenia Gravis Treatment Market

P

2023

Mexico Myasthenia Gravis Treatment Market: Opportunity Analysis and Industry Forecast, 2022 - 2032

The Mexico Myasthenia Gravis Treatment Market is expected to reach a value of $40.8 million by 2032 during the forecast period 2023-2032

Report Code : * A102156 | Pages : 89 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Germany Myasthenia Gravis Treatment Market

P

2023

Germany Myasthenia Gravis Treatment Market: Opportunity Analysis and Industry Forecast, 2022 - 2032

The Germany Myasthenia Gravis Treatment Market was valued at $89.7 million in the year FY2022. The market growth is anticipated to continue during the forecast period, FY2023-FY2032

Report Code : * A102160 | Pages : 86 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Italy Myasthenia Gravis Treatment Market

P

2023

Italy Myasthenia Gravis Treatment Market: Opportunity Analysis and Industry Forecast, 2022 - 2032

The Italy Myasthenia Gravis Treatment Market size is expected to reach $78 million by 2032 during the period from 2023-2032

Report Code : * A102161 | Pages : 80 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Japan Myasthenia Gravis Treatment Market

P

2023

Japan Myasthenia Gravis Treatment Market: Opportunity Analysis and Industry Forecast, 2022 - 2032

The Japan Myasthenia Gravis Treatment Market is expected to reach a value of $236.9 million by 2032 during the forecast period 2023-2032

Report Code : * A102164 | Pages : 75 | Category : Life Sciences

Price:

~~$2,175~~ $1,523 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

China Myasthenia Gravis Treatment Market

P

2023

China Myasthenia Gravis Treatment Market: Opportunity Analysis and Industry Forecast, 2022 - 2032

The China Myasthenia Gravis Treatment Market was valued at $99.6 million in the year FY2022. The market growth is anticipated to continue during the forecast period, FY2023-FY2032

Report Code : * A102165 | Pages : 79 | Category : Life Sciences

Price:

~~$2,175~~ $1,523 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Middle East And Africa Myasthenia Gravis Treatment Market

P

2023

Middle East And Africa Myasthenia Gravis Treatment Market: Opportunity Analysis and Industry Forecast, 2022 - 2032

The Middle East And Africa Myasthenia Gravis Treatment Market is expected to register a CAGR of 6.7% during the forecast period 2023-2032

Report Code : * A102168 | Pages : 79 | Category : Life Sciences

Price:

~~$2,175~~ $1,523 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

France Myasthenia Gravis Treatment Market

P

2023

France Myasthenia Gravis Treatment Market: Opportunity Analysis and Industry Forecast, 2022 - 2032

The France Myasthenia Gravis Treatment Market size reached $50.6 million in 2022. Looking forward it is expected to grow exponentially by 2032 during 2023-2032

Report Code : * A102159 | Pages : 70 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Latin America Myasthenia Gravis Treatment Market

P

2023

Latin America Myasthenia Gravis Treatment Market: Opportunity Analysis and Industry Forecast, 2022 - 2032

The Latin America Myasthenia Gravis Treatment Market size is expected to reach $77.9 million by 2032 during the period from 2023-2032

Report Code : * A102169 | Pages : 79 | Category : Life Sciences

Price:

~~$2,175~~ $1,523 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

U.S. Sleep Aids Market

P

2023

U.S. Sleep Aids Market: Opportunity Analysis and Industry Forecast, 2023–2032

U.S. sleep aids market size was valued at $29,653.33 Million in 2022 and is projected to reach $54,729.19 Million by 2032, registering a CAGR of 6.3% from 2023 to 2032.

Report Code : A265504 | Pages : 135 | Category : Life Sciences

Price:

~~$2,335~~ $1,635 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Ibuprofen Market

P

2024

Ibuprofen Market: Global Opportunity Analysis and Industry Forecast, 2024 - 2033

The global ibuprofen market was valued at $100.0 million in 2023, and is projected to reach $213.6 million by 2033, growing at a CAGR of 7.9% from 2024 to 2033.

Report Code : A65446 | Pages : 280 | Category : Life Sciences

Price:

~~$2,655~~ $1,859 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Glucagon Like Peptide-1

P

2024

Glucagon Like Peptide-1 : Global Opportunity Analysis and Industry Forecast, 2024 - 2033

The global glucagon like peptide-1 (GLP-1) agonists market was valued at $31.3 billion in 2023, and is projected to reach $90.6 billion by 2033, growing at a CAGR of 11.2% from 2024 to 2033.

Report Code : A324075 | Pages : 216 | Category : Life Sciences

Price:

~~$2,655~~ $1,859 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

Results for Tags: medication

Filter by Region

Filter by Discounts

Filter by Category

The global acne medication market was valued at $13.4 billion in 2023, and is projected to reach $24.2 billion by 2035, growing at a CAGR of 5.1% from 2024 to 2035.

The global medication management market was valued at $3.0 billion in 2023, and is projected to reach $8.2 billion by 2033, growing at a CAGR of 10.6% from 2024 to 2033.

The Mexico Myasthenia Gravis Treatment Market is expected to reach a value of $40.8 million by 2032 during the forecast period 2023-2032

The Germany Myasthenia Gravis Treatment Market was valued at $89.7 million in the year FY2022. The market growth is anticipated to continue during the forecast period, FY2023-FY2032

The Italy Myasthenia Gravis Treatment Market size is expected to reach $78 million by 2032 during the period from 2023-2032

The Japan Myasthenia Gravis Treatment Market is expected to reach a value of $236.9 million by 2032 during the forecast period 2023-2032

The China Myasthenia Gravis Treatment Market was valued at $99.6 million in the year FY2022. The market growth is anticipated to continue during the forecast period, FY2023-FY2032

The Middle East And Africa Myasthenia Gravis Treatment Market is expected to register a CAGR of 6.7% during the forecast period 2023-2032

The France Myasthenia Gravis Treatment Market size reached $50.6 million in 2022. Looking forward it is expected to grow exponentially by 2032 during 2023-2032

The Latin America Myasthenia Gravis Treatment Market size is expected to reach $77.9 million by 2032 during the period from 2023-2032

U.S. sleep aids market size was valued at $29,653.33 Million in 2022 and is projected to reach $54,729.19 Million by 2032, registering a CAGR of 6.3% from 2023 to 2032.

The global ibuprofen market was valued at $100.0 million in 2023, and is projected to reach $213.6 million by 2033, growing at a CAGR of 7.9% from 2024 to 2033.

The global glucagon like peptide-1 (GLP-1) agonists market was valued at $31.3 billion in 2023, and is projected to reach $90.6 billion by 2033, growing at a CAGR of 11.2% from 2024 to 2033.